NovaQuest Private Equity Acquires Majority Interest in Clinical Ink

Published on: 

Applied Clinical Trials

Clinical Ink, the pioneering provider of eSource and next-generation ePRO/eCOA solutions for clinical development, announced that the private equity team at NovaQuest has acquired a majority of the outstanding shares of the company from existing investors and provided a substantial infusion of additional growth capital.


Read the full release here.